HomeBUSINESS
BUSINESS

M3 Enters Regenerative Medicine Field, Investing 200 Million Yen in Biotech Firm
(Nov.21.2017)

M3 Inc., a healthcare information provider to physicians, said on November 17 that it has entered into a capital alliance agreement with Osaka-based biotech Genomix, investing 200 million yen in the biotech company ...
(LOG IN FOR FULL STORY)

News Calendar